|
RPD
|
ROYALTY PHARMA OA DL-0001
|
DE
|
F
|
|
SNW
|
Sanofi
|
DE
|
F
|
|
SNW2
|
Sanofi
|
DE
|
F
|
|
TKD
|
Takeda Pharmaceutical Company Limited
|
DE
|
F
|
|
TKDA
|
Takeda Pharmaceutical Company Limited
|
DE
|
F
|
|
UP0
|
Ultragenyx Pharmaceutical Inc
|
DE
|
F
|
|
UTH
|
United Therapeutics Corporation
|
DE
|
F
|
|
XRP2
|
SILENCE THERAP. SP.ADR/1
|
DE
|
F
|
|
YP2A
|
BioLineRx Ltd
|
DE
|
F
|
|
ZEG
|
AstraZeneca PLC
|
DE
|
F
|
|
ZEGA
|
AstraZeneca PLC
|
DE
|
F
|
|
0QF
|
Moderna, Inc.
|
DE
|
XETRA
|
|
NOV
|
Novo Nordisk A/S
|
DE
|
XETRA
|
|
SNW
|
Sanofi
|
DE
|
XETRA
|
|
ZEG
|
AstraZeneca PLC
|
DE
|
XETRA
|
|
4KB
|
Krystal Biotech Inc
|
DE
|
STU
|
|
IM8N
|
Insmed Incorporated
|
DE
|
STU
|
|
MAH0
|
Mereo BioPharma Group plc
|
DE
|
STU
|
|
SAN
|
Sanofi SA
|
FR
|
PA
|
|
DVYSR
|
Devyser Diagnostics AB
|
SE
|
ST
|